Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1999
03/23/1999US5886143 Reagent including at least nine hexose residues connected in iteratively branched configuration, functional moiety capable of reacting with binding moiety, target moiety or active agent
03/23/1999US5886054 Administering to a patient effective doses of scleroglucan and xanthane gum, in combination with electrolyte and preservative; saliva or tears substitute
03/23/1999US5886053 Use of carotenoids for producing drugs for the treatment of dermatoses
03/23/1999US5886051 Methods and compositions for the treatment of neurodegeneration
03/23/1999US5886050 Secondary-amines as an antitumor agents
03/23/1999US5886049 Administering to a patient suffering from systemic lupus erythematodes a therapeutically effective amount of toremifene or salt
03/23/1999US5886048 PHMB for the treatment of tumor disease
03/23/1999US5886047 Topically administering a composition comprising ethyl alcohol as a wound healing agent and lidocaine as an analgesic; urogenital disorders
03/23/1999US5886045 Administering intramucosally to the nose of the mammal an effective amount of an immunoglobulin e antibody inhibitor (2-(4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl)-ethyl) dimethylsulfonium para-toluenesulfonate compound
03/23/1999US5886044 IL-8 receptor antagonists
03/23/1999US5886043 Antiarthritic agents, antitumor agents, antiinflammatory agents
03/23/1999US5886042 Amphoteric compostion and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/23/1999US5886041 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/23/1999US5886040 Ionic combination provides improved taste, increased energy and enhanced metabolism
03/23/1999US5886039 Administering to uretha a lipophilic active agent selected from the group consisting of vasoactive prostaglandins
03/23/1999US5886038 Topically administering to a human a composition having isopropyl myristate as the only active ingredient
03/23/1999US5886036 Treating hiv infections
03/23/1999US5886035 Difluoroprostaglandin derivatives and their use
03/23/1999US5886033 Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders
03/23/1999US5886032 Method of treating cyanide poisoning
03/23/1999US5886031 Administering to a person an effective amount of iodopropynyl butyl carbamate an antibacterial and antidandruff agent with an adsorption-accelerating agents selected from urea, guar hydroxypropyl trimonium chloride, and polyquaternium-10
03/23/1999US5886030 Use of vitamin E tocopheryl derivatives in ophthalmic compositions
03/23/1999US5886029 Method and composition for treatment of diabetes
03/23/1999US5886028 Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse
03/23/1999US5886026 Anti-angiogenic compositions and methods of use
03/23/1999US5886025 Methoxy and ethoxy substituted 3-aroyl-2-arylbenzo(b)thiophenes and benzo(b)thiophene analogues
03/23/1999US5886024 Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors
03/23/1999US5886023 N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidino)acetamide; alzheimer's disease; cerebrovascular dementia; pschological disorders
03/23/1999US5886021 Antiischemic agents; angina pectoris; raynaud's syndrome; centchroman, an estrogen antagonist
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5886019 Protein kinase C modulators. F.
03/23/1999US5886018 Pharmaceutical composition for parenteral administration containing an indole-carboxylic acid
03/23/1999US5886014 Benzimidazole derivatives, their preparation and their therapeutic use
03/23/1999US5886013 Antiviral composition
03/23/1999US5886012 Treating non-insulin dependent diabetes mellitus with nifedipine and calcium carbonate
03/23/1999US5886010 TNF-αinhibitor
03/23/1999US5886009 Quinuclidine derivative as a substance P antagonist
03/23/1999US5886008 5-arylindole derivatives
03/23/1999US5886005 4-Aza-19-norandrostane derivatives
03/23/1999US5886004 Tetrahydrobetacarboline compounds
03/23/1999US5886003 Administering 5-ht2 antagonists
03/23/1999US5886002 Use of rifaximin and of pharmaceutical compositions containing it in the treatment of the diarrhoea from cryptosporidiosis
03/23/1999US5886001 Agonist compounds
03/23/1999US5886000 Anti-HIV agent
03/23/1999US5885998 Administering an effective amount of an aryl subsistituted aliphatic compound, an aryl substituted olefinic amine compound or an aryl substituted acetylenic compound such as 4-(5-pyrimidinyl)-3-butene-1-amine
03/23/1999US5885996 An enzyme inhibitors of thymidylate synthase works as bactericides, fungicides inhibiting yeasts, fungi
03/23/1999US5885993 2-amino-4-(2,4-dichlorophenyl)-s-triazine derivatives
03/23/1999US5885988 Benzo g!quinoline derivatives
03/23/1999US5885986 Cleaving, n-alkylating and reducing the intermediate formed by reacting an oxazolyl and thiazolylimidazobenzo and thienodiazepine derivatives with amine compounds; used as anxiolytic and anticonvulsant or sedative-hypnotic agents
03/23/1999US5885982 Use of transglutaminase inhibitor for the treatment of scar tissue
03/23/1999US5885981 Reacting a halogenated alkyl compound with a penem compound
03/23/1999US5885980 Vo.sup.+2 generating compound and a therapeutically effective amount of micronized glyburide.
03/23/1999US5885979 Squalene synthetase inhibitor treating or preventing hyperlipidemia
03/23/1999US5885978 External therapeutic composition for dermatitis
03/23/1999US5885977 Use of Δ5 androstenes in the treatment of HIV wasting syndrome
03/23/1999US5885973 Bone mass anabolic composition comprising olpadronate
03/23/1999US5885972 L-pyranosyl nucleosides
03/23/1999US5885968 For hypolipidemic medicines
03/23/1999US5885962 Stem cell factor analog compositions and method
03/23/1999US5885960 Method of treatment comprising administering a combination comprising FGF and polyelectrolytes
03/23/1999US5885808 Genetically modifying adenovirus or adenovirus like particle to produce a binding site which is incorporated as a fusion protein with fiber protein, infecting cells with above viruses, culturing and harvesting
03/23/1999US5885805 gbpA
03/23/1999US5885804 Genetic engineered polynucleotides and encoded polypeptides of the atp-binding protein family, treating meningitis, infection of cerebrospinal fluid
03/23/1999US5885786 Methods for screening of substances for inhibition of multidrug resistance
03/23/1999US5885621 Administering a therapeutic gas to the patient, wherein the therapeutic gas comprises a therapeutically effective amount of gaseous nitric oxide (no); sickle cell anemia
03/23/1999US5885612 Recrystallization-free estradiol-containing patch
03/23/1999US5885608 Lipid soluble forms of thiamine for prevention and treatment of age-related cognitive impairment of the nervous system
03/23/1999US5885601 Delivering antibiotic directly to the uterine cavity or fallopian tube of the female in an amount effective to cause sterilization
03/23/1999US5885597 Hydrocortisone, ibuprofen, and at least one of lidocaine and benzocaine; capsaicin, phospholipid, and at least one polyoxyethylenepolyoxypropylene copolymer
03/23/1999US5885595 Treating skin disorder with acne, follicular and lesional papules, actinic keratoses, oily skin and rosacea
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999US5885557 Topical mixture of 1,3-dihydroxyacetone, a penetration attenuator and a carrier; rapid ?sloughing off? of the induced tan from the affected areas; psoriasis; eczema
03/23/1999US5885548 Diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, that contain an element of atomic numbers 20-32, 39-51 for use as contrast media and antidotes
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA2181225C The use of sertraline to treat post myocardial infarction patients
03/23/1999CA2173457C Use of 5-alpha reductase inhibitorsand compositions for treating androg enic alopecia
03/23/1999CA2157393C Preparation for improving the blood supply containing hard magnetic particles
03/23/1999CA2130878C 4-aminopyrimidine derivatives
03/23/1999CA2120028C Indol derivatives for the treatment of migrane
03/23/1999CA2096293C Alkene carboxylic acid derivatives, method of preparation thereof and pharmaceutical compositions containing them
03/23/1999CA2092794C Naphthylalkylamines, process for their preparation and pharmaceutical compositions that contain them
03/23/1999CA2072624C Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
03/23/1999CA2031505C Phospholipid derivative
03/23/1999CA2025858C Antihepatopathic composition
03/23/1999CA2022611C Optical resolution method for 3s-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4s-chromanol
03/23/1999CA2018167C Sustained release pharmaceutical tablet
03/23/1999CA2016181C Arylthiazolylimidazoles as 5ht3 antagonists
03/23/1999CA2009741C Selective antibacterial agent
03/23/1999CA2008771C Pyridinium nitrate, its production and use
03/23/1999CA2002597C Solvates of b-lactam antibiotic
03/23/1999CA1340463C Alkanophenones
03/23/1999CA1340458C 1, 2, 3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists
03/22/1999CA2247749A1 Biphenylsulfonylcyanamides, process for their preparation, and their use as medicament
03/22/1999CA2244239A1 Novel era
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/18/1999WO1999013329A1 Methods of identifying molecules that home to angiogenic vasculature in tumors
03/18/1999WO1999013071A1 Human papilloma virus inhibition by anti-sense oligonucleotides
03/18/1999WO1999012970A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012951A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
1 ... 6524 6525 6526 6527 6528 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 6542 6543 6544 ... 7860